Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Avrobio Inc (NQ: AVRO ) 1.190 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Apr 29, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Avrobio Inc < Previous 1 2 3 4 Next > 12 Health Care Stocks Moving In Wednesday's Intraday Session July 12, 2023 Via Benzinga Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session July 12, 2023 Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market. Via Benzinga Why Avrobio Shares Are Rising Wednesday July 12, 2023 AVROBIO Inc (NASDAQ: AVRO) shares are trading higher Wednesday after the company said it will explore strategic alternatives. Via Benzinga Avrobio Offloads Gene Therapy Program For Rare Genetic Disorder To Novartis May 22, 2023 Via Benzinga Recap: Avrobio Q1 Earnings May 11, 2023 Via Benzinga Avrobio Touts New Positive Data From Gaucher Disease Gene Therapy December 07, 2022 Via Benzinga Recap: Avrobio Q2 Earnings August 09, 2022 Avrobio (NASDAQ:AVRO) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session July 12, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session June 07, 2023 Via Benzinga Avrobio Stock Jumps On Sale Of Gene Therapy Program To Novartis May 22, 2023 Shares of clinical-stage gene therapy company AVROBIO, Inc. (NASDAQ: AVRO) are trading higher Monday due to its agreement to sell its investigational hematopoietic stem cell (HSC) gene therapy program... Via Benzinga Dow Tumbles 100 Points; Micron Technology Shares Plunge May 22, 2023 U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping over 100 points on Monday. The Dow traded down 0.36% to 33,306.30 while the NASDAQ rose 0.39% to 12,707.21. The S&P 500,... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session May 22, 2023 Via Benzinga Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session May 22, 2023 Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share. Via Benzinga Nasdaq Rises Over 50 Points; Greenhill Shares Spike Higher May 22, 2023 U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 50 points on Monday. The Dow traded down 0.20% to 33,359.71 while the NASDAQ rose 0.47% to 12,717.37. The S&P... Via Benzinga Why Is AVROBIO (AVRO) Stock Up 83% Today? May 22, 2023 AVROBIO (AVRO) stock is seeing massive gains on Monday as the company sells one of its gene therapies to Novartis (NVS). Via InvestorPlace 12 Health Care Stocks Moving In Monday's Pre-Market Session May 22, 2023 Via Benzinga Analyst Says Gene Therapy Data Update Offers Insights into Potential Pivotal Endpoints May 18, 2023 Avrobio Inc (NASDAQ: AVRO) shares are trading higher after the company announced follow-up data demonstrating a durable treatment effect across key measures out to 36 months from a Phase 1/2 trial of... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session May 18, 2023 Via Benzinga Avrobio Touts Positive Data Gene Therapy Trial For Cystinosis, Showing Treatment Durability Of Up To 36 Months May 18, 2023 Avrobio Inc (NASDAQ: AVRO) announced follow-up data demonstrating a durable treatment effect across key measures out to 36 months from a Phase 1/2 trial of an investigational gene therapy for... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session March 23, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session January 10, 2023 Via Benzinga AVROBIO Announces Clinical Data For Gaucher Disease Gene Therapy; Says 'Following positive feedback from FDA and MHRA, registrational, global Phase 2/3 clinical trial for GD3 planned for second half 2023' December 07, 2022 New compelling clinical data from first-ever Gaucher disease type 3 (GD3) patient and four Gaucher disease type 1 (GD1) patients dosed with investigational AVR-RD-02 Data from first pediatric GD3... Via Benzinga Protalix and Chiesi Resubmit FDA Application For Rare Disease Treatment November 29, 2022 Protalix BioTherapeutics, Inc. (NYSE AMERICAN: PLX), an Israeli biopharmaceutical company, and Chiesi Global Rare Diseases, a business unit of the Chiesi Group, Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session September 20, 2022 Via Benzinga Under The Hood Of Options Chain Implications — Understanding How Options Data Can Help Inform Investment Decisions September 20, 2022 As many investors are aware, options market data can provide some critical insight into future price movements of underlying common stock. It’s often possible to tell how the broader market perceives a... Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session July 29, 2022 Gainers Nanobiotix (NASDAQ:NBTX) shares rose 16.4% to $2.7 during Friday's after-market session. The company's market cap stands at $94.1 million. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session July 13, 2022 Via Benzinga AVROBIO Shares Climb As FDA Grants Orphan Drug Status To Genetic Disorder Candidate July 13, 2022 The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for AVROBIO’s (NASDAQ: AVRO) lead drug AVR-RD-05 for the treatment of mucopolysaccharidosis type II (MPSII), or Hunter... Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session July 07, 2022 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session June 30, 2022 Gainers Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.